Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept

Pankaj Garg1, Sankalp Mittal2

  • 1General Surgeon, Indus International Hospital, Mohali, Punjab, India.

Abstract

Insights

Mass urine sugar testing can identify uncontrolled diabetes, a key factor in severe post-Covid mucormycosis. This approach helps manage diabetes risk in at-risk populations.

Area of Science:

  • Infectious Diseases
  • Endocrinology
  • Public Health

Background:

  • Post-Covid mucormycosis presents significant morbidity and mortality.
  • Key risk factors include COVID-19 infection, excessive steroid use, and uncontrolled diabetes.

Observation:

  • Uncontrolled diabetes is the most rapidly modifiable risk factor for post-Covid mucormycosis.
  • Screening susceptible populations for asymptomatic mucormycosis using urine-sugar tests is feasible and cost-effective.

Findings:

  • The proposed Mass Urine Sugar Testing to Assess and Regulate Diabetes (MUSTARD) strategy can effectively identify individuals with uncontrolled diabetes.
  • Early identification facilitates timely management of diabetes in high-prevalence populations.

Implications:

  • Implementing MUSTARD can aid in preventing severe outcomes associated with post-Covid mucormycosis.
  • This public health initiative can improve diabetes management and reduce mucormycosis-related mortality.